title: Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
authors.affiliation: Eye Clinic, University of Turin.
authors.forename: B
authors.initials: B
authors.lastname: Boles Carenini
authors.forename: B
authors.initials: B
authors.lastname: Brogliatti
authors.forename: M T
authors.initials: MT
authors.lastname: Dorigo
authors.forename: G
authors.initials: G
authors.lastname: Vadalà
authors.forename: R
authors.initials: R
authors.lastname: Protti
authors.forename: A
authors.initials: A
authors.lastname: Bellone
mesh_terms: D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D014290:Metipranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D008916:Miotics / Q000008:administration & dosage / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use*; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use*; D014065:Tonometry, Ocular; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D008916:Miotics; D009883:Ophthalmic Solutions; D010862:Pilocarpine; D013999:Timolol; D014290:Metipranolol